Transmodulation of EGF receptor by interferon-γ in human hepatocellular carcinoma HepG2 cells

In Vivo

Volumn 11, Issue 2, 1997, Pages 141-146

  Wang, Dongfang ^a   Yang, Er Bin ^a   Lek, Lee Hua ^a   Cheng, Li Yao ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Affinity; Epidermal growth factor receptor; Hepg2 cells; Interferon ; Internalization; Tyrosine phosphorylation

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GAMMA INTERFERON;

ARTICLE; CELL GROWTH; CELL STRAIN HEPG2; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; INTERNALIZATION; LIVER CELL CARCINOMA; PROTEIN PHOSPHORYLATION; TUMOR GROWTH;

EID: 0030912409     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Ullrich A and Schlessinger J: Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203-212, 1990.
2. Fish EN, Ghislain J, Trogadis J and Stevens JK: Inhibitory effect of α-interferon on epidermal growth factor-mediated receptor-dependent events. Cancer Res 5: 5148-5157, 1993.
3. Hamburger AW and Pinnamaheni GD: Increased epidermal growth factor receptor gene expression by γ-interferon in a human breast cell line. Br J Cancer 64: 64-68, 1991.
4. Donato NJ, Gallic GE, Steck PA and Rosenblum MG: Tumor necrosis factor modulates epidermal growth factor receptor phosphorylation and kinase activity in human tumor cells. J Biol Chem 264: 20474-20481, 1989.
5. Yarden Y and Ullrich A: Growth factor receptor tyrosine kinase. Annu Rev Biochem 57: 443-478, 1988.
6. Carpenter G: Receptors for growth factor and other polypeptide mitogens. Annu Rev Biochem 56: 881-914, 1987.
7. Wiley LM, Adamson ED and Tsark EC: Epidermal growth factor receptor function in early mammalian development. BioEssays 17: 839-846, 1995.
8. Carpenter G and Cohen S: Epidermal growth factor. Annu Rev Biochem 48: 193219, 1979.
9. Huslig RL, Mishra S and Hamburger AW: Interferon-enhancement of tyrosine phosphorylation of epidermal growth factor receptors in human breast carcinoma cells. Anticancer Res 13: 613-618, 1993.
10. Mubus VJ, Asphal W, Knapstein PG and Kreienberg R: Effects of interferon-γ on the proliferation and modulation of cell-surface structures of human ovarian carcinoma cell lines. J Cancer Clin Oncol 120: 27-34, 1993.
11. Chakravarthy A, Chen LC, Mehta D and Hamburger AW: Modulation of epidermal growth factor receptors by gamma interferon in a breast cancer cell line. Anticancer Res 11: 347-352, 1991.
12. Aden DP, Fogel A, Plotkin S, Damjanov I and Knowles BB: Controlled synthesis of HBsAg in a differentiated human liver carcinoma derived cell line. Nature 282: 615616, 1979.
13. Yang EB, Wang DF, Mack P and Cheng LY: EGF receptor in human Chang Liver and hepatoma HepG2 cells. Biochem Mol Biol Int 38: 813-820, 1996.
14. Wang DF, Yang EB and Cheng LY: Effects of IFN-γ, TNF-α and EGF on the expression of HLA class I antigen and the proliferation of human hepatocellular carcinoma HepG2 cells. Anticancer Res 17: Accepted.
15. Wang DF, Yang EB and Cheng LY: Modulation of EGF receptor by tumor necrosis factor-α in human hepatocellular carcinoma HepG2 cells. Anticancer Res 16: 3001-3006, 1996.
16. Yang EB, Wang DF, Mack P and Cheng LY: Genistein, a tyrosine kinase inhibitor, reduces EGF-induced EGF receptor internalization and degradation in human hepatoma HepG2 cells. Biochem Biophys Res Comm 224: 309-317, 1996.
17. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
18. Yang EB, Wang DF, Mack P and Cheng LY: Detection of EGF induced EGF receptor degradation and tyrosine phosphorylation in intact cells. J Biochem Biophys Methods 32: 97-108, 1996.
19. Maio M, Gluwani B, Tombesi S, Langer JA, Duiguo GJ, Kerbel RS, Fisher PB and Ferrone S: Differential induction by immune interferon of the gene products of the HLA-D region on the melanoma cell line MeWo and its metastatic variant Mam 50-10. J Immunol 141: 913-920, 1988.
20. Bird TA and Saklatvala J: IL-1 and TNF transmodulate growth factor receptor by a protein kinase C-independent mechanism. J Immunol 142: 126-133, 1989.
21. Norby JG, Ottolengihi P and Jensen J: Scatchard plot: common misinterpretation of binding experiments. Anal Biochem 102: 318-320, 1980.
22. Rosenthal HE: A graphic method for the determination and presentation of binding parameters in a complex system. Anal Biochem 20: 525-532, 1967.
23. Felder S, Miller K, Moehren G, Ullrich A, Schlessinger J and Hopkins CR: Kinase activity controls the sorting of the epidermal growth factor receptor within the multivesicular body. Cell 61: 623-634, 1990.
24. Kawamoto T, Mendelsohn J, Le A, Sato GH, Lazar CS and Gill G N: Regulation of epidermal growth factor receptor concentration to growth of human epidermoid carcinoma A431 cells. J Biol Chem 259: 7761-7766, 1984.
25. Donate NJ, Rosenblum M G and Steck PA: Tumor necrosis factor regulates tyrosine phosphorylation on epidermal growth factor recegtors in A431 carcinoma cells: evidence for a distinct mechanism. Cell Growth and Differ 3: 259-268, 1992.
26. Aguet M: The interferon-γ receptor: A comparison with other cytokine receptors. J Interferon Res 10: 551-558, 1990.
27. Pellegrini S and Schindler C: Early events in signalling by interferons. TIBS 18: 338-342, 1993.
28. Novotny-Smith CL, Zorbas MA, Mcisaac AM, Irimura T, Boman BM, Yeoman LC and Gallick GE: Down-modulation of epidermal growth factor receptor accompanies TNF-induced differentiation of the DiFi human adenocarcinoma cell line toward a goblet-like phenotype. J Cell Phys 157: 253-262, 1993.
29. Worm M, Makki A, Dippel E, Czarnetzki BM and Schadendorf D: Interferon-gamma down regulates epidermal growth factor receptor on human melanoma cells. Exp Dermatol 4: 30-35, 1995.
30. Budillon A, Tagliaferii P, Caraglia M, Torrsi MR, Normanno N, Iacobelli S, Palmieri G, Stoppelli MP, Frati L and Bianco AR: Upregulation of epidermal growth factor receptor induced by α-interferon in human epidermal cancer cells. Cancer Res 51: 1294-1299, 1991.